0

Real-World Data Can Bring Value to Life Sciences Companies Operating in a Value-Based World

The healthcare industry — from providers and health systems to payers — is increasingly adopting value-based care practices, which is not surprising given that approximately 61% of all healthcare payments are tied to value and quality in some way. In… Continue Reading

0

Using Real-World Data for Patients with Multiple Sclerosis: A New Machine Learning Model for the Expanded Disability Status Scale (EDSS)

  Multiple sclerosis (MS) is a chronic illness in which the body’s immune system attacks myelin, the substance that surrounds and protects the nerve fibers of the central nervous system. The result is a disabling disease that causes damage to… Continue Reading

0

Delivering Real World Data-Driven Insights: An Executive Interview with Wendy Shusko and Jason Drenning

Delivering Real World Data-Driven Insights:An Executive Interview with Wendy Shusko and Jason Drenning Wendy Shusko, President and CEO and Jason Drenning, PhD, Chief Commercial Officer of STATinMED Research sat down with HealthEconomics.Com to discuss the data landscape, industry trends and… Continue Reading

0

Real-world evidence and value-based contracting – swipe left or swipe right?

As biopharma makes the shift toward a personalized healthcare system, it is also transitioning towards a pipeline full of innovative, high-cost therapies. We are moving to a value-based system, with two of the biggest ideas for this decade becoming more… Continue Reading

0

Key Elements of a Real-World Evidence Generation Plan: Integration of Product Support Activities

Shelby CormanPharmerit International Real-world evidence is a key component of value demonstration for pharmaceuticals, diagnostic agents, and medical devices throughout the product lifecycle. Planning for real-world evidence needs early in the pre-launch period can allow for seamless integration of health… Continue Reading